Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart Sonoma Pharmaceuticals (Nasdaq:SNOA) announced the U.S. retail launch of its advanced HOCl-based burn relief hydrogel in CVS and Walmart on March 24, 2026. The OTC hydrogel is indicated for minor burns and skin irritations and is marketed via a U.S.-based distribution partner.This is Sonoma's first large-scale consumer burn product, following its 2025 diaper rash hydrogel retail rollout, and complements the company's professional wound and burn care portfolio while leveraging strategic partnerships for mass‑market distribution.

#SNOA Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin Sonoma Pharmaceuticals (Nasdaq:SNOA) on March 18, 2026 launched Aquanil AD, a hypochlorous acid (HOCl) dermatology product line for sensitive skin developed exclusively for Persōn & Covey for U.S. over-the-counter distribution.The line includes Repair Mist, Recovery Gel, and Rescue Serum, each aimed at soothing irritation, reducing scar appearance, and relieving rashes and itching.

#SNOA Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Fundamental analysis of $SNOA (Sonoma Pharmaceuticals, Inc.) based on financial data and reported results.

#SNOA #Sonoma

新スキンケアブランド「Snoa」がもたらす雪のような透明感 新ブランド「Snoa」は、内側から輝く健康的な肌を提案。2026年1月20日より発売開始。特許技術のコラーゲン100%シートと優れたジェルミストで、毎日の肌ケアを格上げします。

新スキンケアブランド「Snoa」がもたらす雪のような透明感 #スキンケア #コラーゲン #Snoa

新ブランド「Snoa」は、内側から輝く健康的な肌を提案。2026年1月20日より発売開始。特許技術のコラーゲン100%シートと優れたジェルミストで、毎日の肌ケアを格上げします。

Introducing Snoa: The New Skincare Brand Promising Radiant Skin Snoa, a revolutionary skincare brand, launches its radiant skin products in January 2026, focusing on nurturing skin's natural glow.

Introducing Snoa: The New Skincare Brand Promising Radiant Skin #Japan #Skincare #Tokyo #beauty #Snoa

透明感あふれる新スキンケアブランド「Snoa」が登場！ 新スキンケアブランド「Snoa」が2026年に誕生！内側から輝く素肌を目指した製品が登場予定。詳細をチェック！

透明感あふれる新スキンケアブランド「Snoa」が登場！ #スキンケア #Snoa #スノア

新スキンケアブランド「Snoa」が2026年に誕生！内側から輝く素肌を目指した製品が登場予定。詳細をチェック！

雪のような透明感を叶える新スキンケア「Snoa」登場 アジアンブリッジ社から新スキンケアブランド「Snoa」が誕生。透明な雪の輝きを肌に宿す製品が2026年1月20日に販売開始。注目のケア法を詳しく解説します。

雪のような透明感を叶える新スキンケア「Snoa」登場 #東京都 #千代田区 #スキンケア #アジアンブリッジ #Snoa

アジアンブリッジ社から新スキンケアブランド「Snoa」が誕生。透明な雪の輝きを肌に宿す製品が2026年1月20日に販売開始。注目のケア法を詳しく解説します。

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced Sonoma Pharmaceuticals (Nasdaq: SNOA) announced on November 13, 2025 that Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel earned the National Rosacea Society Seal of Acceptance. The Seal identifies products clinically evaluated and found unlikely to irritate sensitive rosacea skin. Reliefacyn previously earned the National Eczema Association Seal of Acceptance and the National Psoriasis Foundation Seal of Recognition, highlighting Sonoma's Microcyn-based skincare portfolio and focus on products for chronic skin conditions.

#SNOA National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

www.stocktitan.net/news/SNOA/national-rosac...

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results Revenues increased 57% for the quarter and 38% for the six months ended September 30, 2025 compared to same periods last yearU.S. revenue increased 115% for the quarter and 86% for the six months ended September 30, 2025 compared to same periods last yearNet loss per share decreased 46% for the

#SNOA Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals Sonoma Pharmaceuticals (Nasdaq:SNOA) announced the launch of a new HOCl wound cleanser manufactured by Sonoma for Medline Industries, LP, on October 14, 2025.The product will be distributed by Medline into U.S. hospital systems, home healthcare and other healthcare channels. The collaboration between Sonoma and Medline began in 2024 and pairs Sonoma's Microcyn technology with Medline's nationwide distribution to provide clinicians an advanced wound-cleansing option that aims to promote healing and reduce infection risk without harming healthy tissue.

#SNOA Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA Sonoma Pharmaceuticals (Nasdaq:SNOA) announced on October 7, 2025 that it has registered its manufacturing facility and listed a Microcyn-based facial spray under the FDA's Modernization of Cosmetics Regulation Act (MoCRA). The MoCRA registration enables Sonoma to manufacture and commercialize Microcyn technology products as cosmetics in the U.S., expanding the company's regulatory footprint beyond its existing FDA medical device establishment registration and 510(k)-cleared portfolio.The company said this step increases access to U.S. cosmetics and dermatology consumer markets, citing a projected U.S. skin care market near $40 billion by 2030, and positions Sonoma to pursue growth with its patented hypochlorous acid technology.

#SNOA Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Leading Skin Treatment Reliefacyn Advanced Receives Prestigious NPF Seal for Psoriasis Care Sonoma Pharmaceuticals' Reliefacyn Advanced Hydrogel earns NPF Seal of Recognition for safety and efficacy. Product previously received National Eczema Association approval.

#SNOA National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

www.stocktitan.net/news/SNOA/national-psori...

Most Searched, Thursday August 14, 2025 – Crystal Equity Research

Most searched small-cap stocks, Thu Aug 14th - #XOS #ALTS #ATNF #HBI #LUNR #ONDS #SNOA #UAA #DNN #SLDP #OPEN #VNET #UWMC #DLO #FFAI #SBET #ESPR #CMP #AEO #BKV - More: crystalequityresearch.com/most-searche... - #smallcap

BREAKING NEWS: ( NASDAQ: #SNOA ) Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Rises Sharply in 8/14 Early Trading Session

🚀 Excitement is brewing for #SNOA as trading volume skyrockets! With a price jump to $6.07, fueled by new product buzz and earnings anticipation, this penny stock is on the move. Consider a long position at $6.00, targeting $7.50-$8.00. Stay sharp, volatility ahead! 📈 #Stocks #FeetrAI

Sonoma's First Major Consumer Product Hits Walmart Shelves: New Tech-Based Diaper Rash Treatment Biotech firm expands into consumer healthcare with antimicrobial hydrogel using patented Microcyn technology. Now available at Walmart, Amazon, and major grocers. See details.

#SNOA Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Sonoma Pharmaceuticals Earnings Reveal Record-Breaking US Growth, Global Expansion Accelerates Q1 FY2026 shows strong momentum with 57% US growth, retail expansion, and new market approvals. EBITDA and cash position details inside. See full results.

#SNOA Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results

www.stocktitan.net/news/SNOA/sonoma-pharmac...

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results Sonoma Pharmaceuticals (NASDAQ:SNOA) reported strong financial results for FY2025 and Q4 2025, showing significant improvements across key metrics. Q4 revenue increased 9% to $3.8M, while FY2025 revenue grew 12% to $14.3M. The company reduced its net loss by 27% in Q4 and 29% for the full year. EBITDA loss improved substantially, down 59% in Q4 and 17% for FY2025. Gross profit margins improved to 41% in Q4 2025 from 32% in Q4 2024. Notable achievements include early compliance with EU Medical Device Regulation, MHRA registration in the UK, and expanded distribution networks. The company launched acne products in 1,200+ UK stores and received regulatory approval in Ukraine. Operating expenses decreased by 13% in Q4 and 3% for the full year, reflecting successful cost containment efforts. As of March 31, 2025, cash position stood at $5.4M.

#SNOA Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

www.stocktitan.net/news/SNOA/sonoma-pharmac...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Wed Apr 23rd - #RXRX #SOUN #JBLU #RIG #WULF #SNOA #AREB #ZIM #BB #TGB #CLSK #STNE #SMR #SLXN #QS #QBTS #CEP #BTCS #BORR #ASM - More: crystalequityresearch.com/SmCpStr/ - #smallcap

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks in new uptrend with average directional index, Wed Apr 23rd - #AREN #OKYO #GAUZ #VBTX #SIGA #RLMD #PESI #NEON #SNOA #JANX #IRIX #FHTX #EDIT #DRCT #CNCK #AMLX - More: crystalequityresearch.com/SmCpStr/ - #smallcap

NEWS: ( NASDAQ: #SNOA ) Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) Rises Sharply in 4/23 Early Trading Session

BREAKING NEWS: ( NASDAQ: #SNOA ) UK Retail Deal Sparks Early Buying Frenzy in Pharma Stock

Just In: ( NASDAQ: #SNOA ) Sonoma Pharmaceuticals Launches in Major UK Pharmacy Chain after Securing UK Registration for Acne Products

Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain Sonoma Pharmaceuticals (NASDAQ:SNOA) has announced the successful registration of its hypochlorous acid-based acne products with the UK's Medicines & Healthcare products Regulatory Agency (MHRA). The company will launch its products through a major UK pharmacy chain, reaching over 1,200 stores nationwide.The product line features an acne toner and balancing serum, which will be marketed under the retailer's private label brand. These products are based on Sonoma's patented Microcyn technology, utilizing stabilized hypochlorous acid (HOCl). The formulation offers a natural alternative to traditional acne treatments containing alcohol and benzoyl peroxide.

#SNOA Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain

www.stocktitan.net/news/SNOA/sonoma-pharmac...

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Tue Mar 11th - #FUBO #CORZ #AG #HSAI #JBLU #HL #WULF #TSVT #IQ #VRN #RGTI #SNOA #VKTX #QBTS #NNOX #LUNR #LPG #FRO #CDE #ARVN - More: crystalequityresearch.com/SmCpStr/ - #smallcap

How Sonoma Pharmaceuticals Plans to Expand Its Dermatology Footprint at Major 2025 Industry Event Sonoma will exhibit its prescription and OTC dermatology products at the 2025 AAD Annual Meeting, aiming to expand its distributor network in Orlando.

#SNOA Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando

www.stocktitan.net/news/SNOA/sonoma-pharmac...